Blog

Justin shares his success with a novel treatment for non-Hodgkin lymphoma – NCI Center for Cancer Research

Photo taken from NCI Center for Cancer Research/LinkedIn

Sep 13, 2024, 15:50

Justin shares his success with a novel treatment for non-Hodgkin lymphoma – NCI Center for Cancer Research

NCI Center for Cancer Research shared the following post on LinkedIn:

“Justin joined a CCR trial in 2020 and benefited from a novel 5-drug treatment called ViPOR for non-Hodgkin lymphoma. His doctor describes him as likely cancer-free.

‘I wouldn’t be here without NCI,’ Justin effused. ‘The NIH Clinical Center is one of the country’s best-kept secrets.’

Read his full story.”

Source: NCI Center for Cancer Research/LinkedIn

cancer cancer breakthroughs cancer free Cancer research cancer treatment cancer trials clinical trials innovative cancer therapies lymphoma treatment NCI Center for Cancer Research NIH Clinical Center Non Hodgkin lymphoma OncoDaily Oncology ViPOR

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage